APE1/REF-1 REDOX ACTIVITY INHIBITOR AS A NOVEL ORAL TREATMENT FOR INFLAMMATORY BOWEL DISEASE

APX3330 - Apexian, Opus Genetics

https://eposters.ddw.org/ddw/2025/ddw-2025/4154826/ainsley.robinson.ape1.ref-1.redox.activity.inhibitor.as.a.novel.oral.treatment.html?f=menu%3D6%2Abrowseby%3D8%2Asortby%3D2%2Ace_id%3D2855%2Aot_id%3D31408%2Amarker%3D5698

Ainsley M Robinson 1,4; Lauren Sahakian 1; Rhian Stavely 5; Rajaraman Eri 6; Joel Bornstein 2; Vasso Apostolopoulos 1,6,3; Mark R. Kelley 7; Kulmira Nurgali 1,2,3

Mar 8, 2025